2014 WAFSF on Stem Cell Research and Regenerative Medicine
THE IMPACT OF REGENERATIVE MEDICINE 2014
|Date:||Thursday November 6 and Friday, November 7th, 2014|
|Location:||Mission Bay Conference Center at UCSF, 1675 Owens Street, San Francisco, CA 94143|
|Organizer:||Alliance Forum Foundation, USA (AFFUSA)|
|Tickets:||General Registration: $800; Early-bird (July 14-September 12): $640.
Register by Friday, September 12th and you can receive a $160 savings off the standard rate.
For further inquiries or offers on special rates, email us at firstname.lastname@example.org.
|Opening & Welcome Remarks: Mr. Isao “Steve” Matsuura, Conference Co-chair and Council Member, Alliance Forum Foundation and The Honorable Masato Watanabe, Consul General, The Consulate General of Japan in San Francisco|
|First Day Keynote Speaker to be announced|
|Panel Discussion on “Regenerative Medicine 2014” moderated by Michael Werner, Executive Director, Alliance for Regenerative Medicine (ARM) with panelists representing R&D, Investors, Big Pharma/bio venture companies, Enabling Technology Providers, Patient Advocates, and Regulators|
|Lunch||Lunch in the Fischer Banquet Room|
|Afternoon||Speech: Overview of Regenerative Medicine Space
Dr. Mahendra Rao, Vice President of Regenerative Medicine, New York Stem Cell Foundation and Former Director, NIH Center for Regenerative Medicine
|Introduction of Dr. Yamanaka by Mr. Hiro Ogawa, Chairman, 2014 WAFSF Advisory Board and Chair, ISSCR Global Advisory Council|
|Presentation: Dr. Shinya Yamanaka, CiRA, Kyoto University|
|Panel Discussion moderated by Dr. Shinya Yamanaka, CiRA, Kyoto University.
Among the panelists are: Mr. Masayo Tada, Representative Director, President and CEO, Dainippon Sumitomo Pharm Co., Ltd. And Dr. Hardy T S Kagimoto, President and CEO, Healios KK
|Closing Remarks: Mr. George Hara, Chairman, Alliance Forum Foundation|
|Reception||Cocktail Reception in the Main Lobby (1st Floor)|
PROGRAM – DAY 2
|Welcome remarks by Mr. George Hara, Chairman, Alliance Forum Foundation|
|Second Day Keynote Speaker to be announced.|
|Presentations by Dr. Maria-Grazia Roncarolo, Professor of Pediatrics and Medicine, and others.|
|Company Presentation 1
Company Presentation 2
|Presentations moderated by Dr. Hiromitsu Nakauchi, Stanford University and Tokyo University with Dr. Hideyuki Okano, Keio University, Dr. Koji Eto, Kyoto University and Dr. Yoshiki Sawa, Division of Medicine Graduate School of Medicine, Osaka University|
|Company Presentation 3
Company Presentation 4
|Lunch||Lunch in Fischer Banquet Room|
|Afternoon||Presentations moderated by Dr. Deepak Srivastava. Gladstone Institutes with two speakers|
|Company Presentation 5
Company Presentation 6
|Presentations moderated by Dr. Hiromitsu Nakauchi, Stanford University and Tokyo University with two speakers|
|Company Presentation 7
Company Presentation 8
|Presentations introduced by Dr. Hiromitsu Nakauchi, The University of Tokyo with Dr. Takenori Takebe, Yokohama City University and Dr. Shoji Takeuchi, The University of Tokyo|
|Company Presentation 9
Company Presentation 10
|Panel Discussion of leading businesses in the stem cell field|
|Speech by Dr. Regis Kelly, Director, QB3, UCSF|
|Panel Discussion moderated by Dr. Regis Kelly, Director, QB3|
|Concluding Remarks: Mr. George Hara, Chairman, Alliance Forum Foundation|
Please visit this link to learn about business opportunities available at this year’s Conference.
Stem cell research is quickly developing today, as are the possibilities of its applications, which range from disease research and drug development to experimental growth of entirely new organs. Stem-cell technologies harbor the potential for a paradigm shift in regenerative medicine, healthcare, and society at large. However, many challenges still need to be overcome before we will be able to reap the benefits.
- discuss the exciting possibilities of stem-cell applications and how they will affect our future;
- examine the accompanying research and business and regulatory hurdles;
- facilitate the establishment of networks of researchers, entrepreneurs, large corporations, policy-makers, and patient advocates for the development of regenerative medicine as a sustainable industry; and
- encourage the building of a new business environment where “public interest” becomes the guiding standard and where successful businesses reallocate a portion of their profit to basic research, as well as to other stakeholders in the new ecosystem.
The Conference will be lead by internationally recognized figures working primarily in the Bay Area and Japan. The Conference will also bring together venture capital and businesses already involved in, or expected to play a significant role in, the future development of regenerative medicine as a new health delivery system. We also look forward to the participation of regulators, rare disease philanthropists, and patient advocates so that a diverse range of stakeholders will be represented.
With its sessions, pre-session workshops, and business presentations, the Conference will provide the best opportunity to meet with people from the Bay Area and Japan, share views and knowledge, build new relationships, and explore business opportunities!